Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11231)
All Articles published online
|
Publishing Process of This Article
|
Jul 26, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rizos CV, Elisaf MS. Antihypertensive drugs and glucose metabolism. World J Cardiol 2014; 6(7): 517-530 [PMID: 25068013 DOI: 10.4330/wjc.v6.i7.517] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i7/517.htm |
| Number | Citing Articles |
| 1 |
Esther Oluwasola Aluko, Victor Udo Nna, Adesoji Adedipe Fasanmade. Angiotensin converting enzyme inhibitor potentiates the hypoglycaemic effect of NG-nitro-L-arginine methyl ester (L-NAME) in rats. Archives of Physiology and Biochemistry 2022; 128(6): 1524 doi: 10.1080/13813455.2020.1780263
|
| 2 |
Md Yousof Ali, Sumera Zaib, Susoma Jannat, Imtiaz Khan. Inhibition of Angiotensin-I Converting Enzyme by Ginsenosides: Structure–Activity Relationships and Inhibitory Mechanism. Journal of Agricultural and Food Chemistry 2021; 69(21): 6073 doi: 10.1021/acs.jafc.1c01231
|
| 3 |
Elisabeta Badila, Cristina Japie, Ana-Maria Vrabie, Adrian Badila, Adriana Georgescu. Cardiovascular Disease as a Consequence or a Cause of Cancer: Potential Role of Extracellular Vesicles. Biomolecules 2023; 13(2): 321 doi: 10.3390/biom13020321
|
| 4 |
Simona Frontoni, Fabiana Picconi. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Endocrinology 2018; : 1 doi: 10.1007/978-3-319-27316-7_19-1
|
| 5 |
Niki Katsiki, Manfredi Rizzo, Dimitri P. Mikhailidis, Christos S. Mantzoros. New-Onset Diabetes and Statins: Throw the Bath Water Out, But, Please, Keep the Baby!. Metabolism 2015; 64(4): 471 doi: 10.1016/j.metabol.2014.11.001
|
| 6 |
Dongwon Yi, Yang Ho Kang. Drug-Induced Diabetes Mellitus. The Journal of Korean Diabetes 2017; 18(3): 160 doi: 10.4093/jkd.2017.18.3.160
|
| 7 |
Yinghui Wang, Yonggang Wang, Xiaorong Han, Jian Sun, Cheng Li, Binay Kumar Adhikari, Jin Zhang, Xiao Miao, Zhaoyang Chen. Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.727487
|
| 8 |
Huanhuan Hu, Ai Hori, Chihiro Nishiura, Naoko Sasaki, Hiroko Okazaki, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Kentaro Tomita, Toshiaki Miyamoto, Satsue Nagahama, Akihiko Uehara, Makoto Yamamoto, Taizo Murakami, Chii Shimizu, Makiko Shimizu, Masafumi Eguchi, Takeshi Kochi, Teppei Imai, Akiko Okino, Keisuke Kuwahara, Ikuko Kashino, Shamima Akter, Kayo Kurotani, Akiko Nanri, Isamu Kabe, Tetsuya Mizoue, Naoki Kunugita, Seitaro Dohi, Massimo Pietropaolo. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study. PLOS ONE 2016; 11(7): e0159071 doi: 10.1371/journal.pone.0159071
|
| 9 |
Francisco J. Tinahones, Baptist Gallwitz, Matias Nordaby, Sophia Götz, Mario Maldonado‐Lutomirsky, Hans J. Woerle, Uli C. Broedl. Linagliptin as add‐on to empagliflozin and metformin in patients with type 2 diabetes: Two 24‐week randomized, double‐blind, double‐dummy, parallel‐group trials. Diabetes, Obesity and Metabolism 2017; 19(2): 266 doi: 10.1111/dom.12814
|
| 10 |
Jia Yao, Xiayu Gong, Xiaoyan Shi, Simin Fan, Junmin Chen, Qiu Chen. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients. Medicine 2020; 99(24): e20674 doi: 10.1097/MD.0000000000020674
|
| 11 |
Diana Jiménez-Rodríguez, Manuela Conesa-Garcerán, Teresa Belmonte-García. Evaluation of the effect of relaxation therapy in patients with arterial hypertension. Enfermería Clínica (English Edition) 2019; 29(3): 178 doi: 10.1016/j.enfcle.2018.10.002
|
| 12 |
Thiruvinvamalai S. Dharmarajan, Lekshmi Dharmarajan. Tolerability of Antihypertensive Medications in Older Adults. Drugs & Aging 2015; 32(10): 773 doi: 10.1007/s40266-015-0296-3
|
| 13 |
Mohamed A. Morsy, Gehan H. Heeba, Magda E. Mahmoud. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats. European Journal of Pharmacology 2015; 750: 90 doi: 10.1016/j.ejphar.2015.01.027
|
| 14 |
L.V. Zhuravlyova, T.A. Rohachova , N.V. Sokolnikova , O.O. Yankevich . Insulin resistance and cardiovascular diseases: focus on common in pathogenesis and treatment.. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2023; 2023(2): 46 doi: 10.15407/internalmed2023.02.046
|
| 15 |
Maria Marketou, Yashaswi Gupta, Shashank Jain, Panos Vardas. Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol. Current Hypertension Reports 2017; 19(3) doi: 10.1007/s11906-017-0716-3
|
| 16 |
Catarina Santos, Rui Carvalho, Ana Mafalda Fonseca, Miguel Castelo Branco, Marco Alves, Ivana Jarak. Standard Doses of Cholecalciferol Reduce Glucose and Increase Glutamine in Obesity-Related Hypertension: Results of a Randomized Trial. International Journal of Molecular Sciences 2024; 25(6): 3416 doi: 10.3390/ijms25063416
|
| 17 |
|
| 18 |
Maria Alessandra Gammone, Konstantinos Efthymakis, Nicolantonio D’Orazio, Eric Gumpricht. Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen. Journal of Nutrition and Metabolism 2021; 2021: 1 doi: 10.1155/2021/5767306
|
| 19 |
I. V. Kim, E. V. Bochkareva, Yu. Ya. Varakin. Cerebrovascular disease screening in general medical practice: methodological aspects. Profilakticheskaya meditsina 2017; 20(5): 59 doi: 10.17116/profmed201720559-64
|
| 20 |
Francine K. Welty, Abdulhamied Alfaddagh, Tarec K. Elajami. Targeting inflammation in metabolic syndrome. Translational Research 2016; 167(1): 257 doi: 10.1016/j.trsl.2015.06.017
|
| 21 |
Manal M. Alem. Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: A cross-sectional study. Heliyon 2022; 8(11): e11549 doi: 10.1016/j.heliyon.2022.e11549
|
| 22 |
Ti Yin, Shu-Chen Kuo, Yea-Yuan Chang, Yung-Tai Chen, Kai-Wei Katherine Wang. Verapamil Use Is Associated With Reduction of Newly Diagnosed Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2017; 102(7): 2604 doi: 10.1210/jc.2016-3778
|
| 23 |
Simona Frontoni, Fabiana Picconi. Diabetes Complications, Comorbidities and Related Disorders. Endocrinology 2018; : 541 doi: 10.1007/978-3-319-44433-8_19
|
| 24 |
Rami Al Batran, Keshav Gopal, Hanin Aburasayn, Amina Eshreif, Malak Almutairi, Amanda A. Greenwell, Scott A. Campbell, Bruno Saleme, Emily A. Court, Farah Eaton, Peter E. Light, Gopinath Sutendra, John R. Ussher. The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity. JCI Insight 2019; 4(1) doi: 10.1172/jci.insight.124643
|
| 25 |
Mortaza Fatehi Hassanabad, Mohammad Fatehi. Current Views on Dopaminergic Drugs Affecting Glucose Homeostasis. Current Diabetes Reviews 2019; 15(2): 93 doi: 10.2174/1573399814666180424123912
|
| 26 |
Xiao Tan, Christian Benedict. Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication. BMJ Open Diabetes Research & Care 2020; 8(1): e001702 doi: 10.1136/bmjdrc-2020-001702
|
| 27 |
Marie-Anne Heurtebize, Jean-Luc Faillie. Drug-induced hyperglycemia and diabetes. Therapies 2024; 79(2): 221 doi: 10.1016/j.therap.2023.09.010
|
| 28 |
Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, Giovanna Gallo, Allegra Battistoni, Giuliano Tocci, Massimo Volpe. ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients. High Blood Pressure & Cardiovascular Prevention 2021; 28(3): 255 doi: 10.1007/s40292-021-00443-z
|
| 29 |
Kazunori Shimada, Katsumi Miyauchi, Hiroyuki Daida. Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders. Expert Review of Cardiovascular Therapy 2015; 13(1): 23 doi: 10.1586/14779072.2015.986464
|
| 30 |
Briana J. Taylor, Karen A. Matthews, Brant P. Hasler, Kathryn A. Roecklein, Christopher E. Kline, Daniel J. Buysse, Howard M. Kravitz, Alaina G. Tiani, Sioban D. Harlow, Martica H. Hall. Bedtime Variability and Metabolic Health in Midlife Women: The SWAN Sleep Study. Sleep 2016; 39(2): 457 doi: 10.5665/sleep.5464
|
| 31 |
Jovana Jeremic, Natalia Govoruskina, Jovana Bradic, Isidora Milosavljevic, Ivan Srejovic, Vladimir Zivkovic, Nevena Jeremic, Tamara Nikolic Turnic, Irena Tanaskovic, Stefani Bolevich, Vladimir Jakovljevic, Sergey Bolevich, Marko N. Zivanovic, Nduka Okwose, Dragana Seklic, Nevena Milivojevic, Jelena Grujic, Lazar Velicki, Guy MacGowan, Djordje G. Jakovljevic, Nenad Filipovic. Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy. Molecular and Cellular Biochemistry 2023; 478(12): 2645 doi: 10.1007/s11010-023-04690-7
|
| 32 |
Hatice Ozcaliskan Ilkay, Habibe Sahin, Fatih Tanriverdi, Gulhan Samur. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus. Journal of the American College of Nutrition 2019; 38(1): 31 doi: 10.1080/07315724.2018.1476194
|
| 33 |
Diego Soares Carvalho, Alexandre Aparecido de Almeida, Aurélio Ferreira Borges, Diego Vannucci Campos. Treatments for diabetes mellitus type II: New perspectives regarding the possible role of calcium and cAMP interaction. European Journal of Pharmacology 2018; 830: 9 doi: 10.1016/j.ejphar.2018.04.002
|
| 34 |
Martha B. Ramírez-Rosas, Adriana L. Perales-Torres, Rubén Santiago-Adame. Ethnomedicinal Plant Use and Practice in Traditional Medicine. Advances in Medical Diagnosis, Treatment, and Care 2020; : 105 doi: 10.4018/978-1-7998-1320-0.ch006
|
| 35 |
Kahomi Sazawa, Kohei Ohno, Tomohisa Yamashita, Shoya Ino, Satoru Shibata, Takahito Itoh, Hiroyuki Hotta, Tomoaki Matsumoto, Hitoshi Ooiwa, Hirofumi Kubo, Takayuki Miki. Effects of Sacubitril/Valsartan on Glycemic Control in Japanese Patients With Heart Failure and/or Hypertension. Circulation Reports 2022; 4(12): 588 doi: 10.1253/circrep.CR-22-0109
|
| 36 |
S-W Chang, C W McDonough, Y Gong, T A Johnson, T Tsunoda, E R Gamazon, M A Perera, A Takahashi, T Tanaka, M Kubo, C J Pepine, J A Johnson, R M Cooper-DeHoff. Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes. The Pharmacogenomics Journal 2018; 18(1): 106 doi: 10.1038/tpj.2016.67
|
| 37 |
Martha B. Ramírez-Rosas, Adriana L. Perales-Torres, Rubén Santiago-Adame. Research Anthology on Recent Advancements in Ethnopharmacology and Nutraceuticals. 2022; : 323 doi: 10.4018/978-1-6684-3546-5.ch017
|
| 38 |
Gergely Fehér, Gabriella Pusch. Role of antihypertensive drugs in the treatment of migraine. Orvosi Hetilap 2015; 156(5): 179 doi: 10.1556/OH.2015.30056
|
| 39 |
Débora Dias de Lucena, João Roberto de Sá, José O. Medina-Pestana, Érika Bevilaqua Rangel. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study. Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/1938703
|
| 40 |
Mieczysław Litwin, Janusz Feber, Anna Niemirska, Jacek Michałkiewicz. Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities. Pediatric Nephrology 2016; 31(2): 185 doi: 10.1007/s00467-015-3065-y
|
| 41 |
Icilma V. Fergus, Kenneth L. Connell, Keith C. Ferdinand. A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk. Current Cardiology Reports 2015; 17(6) doi: 10.1007/s11886-015-0592-x
|
| 42 |
Maria Greabu, Silviu Constantin Badoiu, Iulia-Ioana Stanescu-Spinu, Daniela Miricescu, Alexandra Ripszky Totan, Silvia Elena Badoiu, Michel Costagliola, Viorel Jinga. Drugs Interfering with Insulin Resistance and Their Influence on the Associated Hypermetabolic State in Severe Burns: A Narrative Review. International Journal of Molecular Sciences 2021; 22(18): 9782 doi: 10.3390/ijms22189782
|
| 43 |
Wilma S. Leslie, Eman Ali, Leanne Harris, C. Martina Messow, Naomi T. Brosnahan, George Thom, E. Louise McCombie, Alison C. Barnes, Naveed Sattar, Roy Taylor, Michael E. J. Lean. Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia 2021; 64(9): 1927 doi: 10.1007/s00125-021-05471-x
|
| 44 |
Elizabeth Black, Jason Lee, Joseph T. Flynn, Charles E. McCulloch, Joshua A. Samuels, Divya Seth, Bradley Warady, Susan Furth, Mark Mitsnefes, Elaine Ku. Discordances between pediatric and adult thresholds in the diagnosis of hypertension in adolescents with CKD. Pediatric Nephrology 2022; 37(1): 179 doi: 10.1007/s00467-021-05166-w
|
| 45 |
Jin Wook Lee, Hyun-Oh Gu, Yunshin Jung, YunJae Jung, Seung-Yong Seo, Jeong-Hee Hong, In-Sun Hong, Dae Ho Lee, Ok-Hee Kim, Byung-Chul Oh. Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation. Experimental & Molecular Medicine 2023; 55(5): 910 doi: 10.1038/s12276-023-00982-6
|
| 46 |
Simona Frontoni, Fabiana Picconi. Diabetes Complications, Comorbidities and Related Disorders. Endocrinology 2019; : 1 doi: 10.1007/978-3-319-27316-7_19-2
|
| 47 |
Ye Seul Yang, Min Hyuk Lim, Seong Ok Lee, Eun Roh, Chang Ho Ahn, Soo Heon Kwak, Young Min Cho, Sungwan Kim, Andrea Mari, Kyong Soo Park, Hye Seung Jung. Fimasartan increases glucose‐stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine. Diabetes, Obesity and Metabolism 2018; 20(7): 1670 doi: 10.1111/dom.13282
|
| 48 |
O. A. Polyakova, O. D. Ostroumova. Features of management of patients with cardiometabolic polymorbidity phenotype: focus on the efficacy and safety of bisoprolol. Meditsinskiy sovet = Medical Council 2023; (16): 11 doi: 10.21518/ms2023-220
|
| 49 |
Yang Zhao, Qiongying Wang, Xu Zhao, Huitao Meng, Jing Yu. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies. Clinical and Experimental Hypertension 2018; 40(1): 22 doi: 10.1080/10641963.2017.1288736
|
| 50 |
Diego Castro Musial, Regiane Miranda‐Ferreira, Juan Fernando Padin, Juan Alberto Arranz‐Tagarro, Alberto J. Parra‐Vitela, Aron Jurkiewicz, Antonio Garcia Garcia, Neide Hyppolito Jurkiewicz. Function of AT1 and AT2 receptors in atrial contractions from spontaneous hypertensive and diabetic‐induced streptozotocin rats. Clinical and Experimental Pharmacology and Physiology 2018; 45(12): 1274 doi: 10.1111/1440-1681.13019
|
| 51 |
Simona Frontoni, Fabiana Picconi. Diabetes Complications, Comorbidities and Related Disorders. Endocrinology 2020; : 541 doi: 10.1007/978-3-030-36694-0_19
|
| 52 |
Ghada M. Ahmed, Mohammed N. Abed, Fawaz A. Alassaf. Impact of calcium channel blockers and angiotensin receptor blockers on hematological parameters in type 2 diabetic patients. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3): 1817 doi: 10.1007/s00210-023-02731-y
|
| 53 |
Neila Fathallah, Raoudha Slim, Sofien Larif, Houssem Hmouda, Chaker Ben Salem. Drug-Induced Hyperglycaemia and Diabetes. Drug Safety 2015; 38(12): 1153 doi: 10.1007/s40264-015-0339-z
|
| 54 |
Diana Jiménez-Rodríguez, Manuela Conesa-Garcerán, Teresa Belmonte-García. Evaluación del efecto de la terapia de relajación en pacientes con hipertensión arterial. Enfermería Clínica 2019; 29(3): 178 doi: 10.1016/j.enfcli.2018.07.005
|